Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022

オリゴヌクレオチド合成の世界市場予測(~2022年):商品別(プライマー、プローブ、リンカー、アダプター、カスタムオリゴ、試薬、機器)、用途別(PPCR、DNA、RNAi、研究、治療)、エンドユーザー別(学術研究機関、医薬品、バイオテクノロジー)

◆タイトル:Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022
◆商品コード:MAM-BT-2680
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年2月6日
◆ページ数:274
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ技術
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥598,900見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥704,900見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥863,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、オリゴヌクレオチド合成の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類別分析、セグメント別分析、地域別分析、オリゴヌクレオチド合成の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・オリゴヌクレオチド合成市場:商品別
・オリゴヌクレオチド合成市場:用途別
・オリゴヌクレオチド合成市場:エンドユーザー別
・オリゴヌクレオチド合成市場:地域別
・競争状況
・企業プロファイル
・付録

“The global oligonucleotide synthesis market projected to grow at a CAGR of 10.9%.”
The global oligonucleotide synthesis market is expected to reach USD 2.46 billion by 2022 from USD 1.47 billion in 2017 at a CAGR of 10.9%. This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques.
Growth in this market is mainly driven the increasing R&D expenditure by pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides from the growing field of molecular diagnostics, rising venture capital investments, and increasing demand for synthetic genes. However, the price erosion of synthesized oligos and lack of regulations for therapeutic oligos are some factors that may hinder the growth of this market.

“Synthesized oligonucleotides are expected to grow at the highest CAGR during the forecast period.”
Based on product, the market is segmented into synthesized oligonucleotides, reagents, and equipment. The synthesized oligonucleotides segment is expected to grow at the highest CAGR during the forecast period The increasing number of applications of synthesized oligonucleotides in research, diagnostics, and therapeutics is a key market driver in this segment. The rising availability and demand for custom oligos also contribute to the growth of the synthesized oligonucleotides market.

“The research segment is expected to hold the largest share of the market in 2017.”
Based on application, the market is segmented into research, diagnostics, and therapeutics. The research segment is estimated to hold the largest share of the oligonucleotide synthesis market in 2017. The market growth for research applications is mainly driven by the developments in the fields of gene synthesis and NGS. Oligos are widely used in technologies such as PCR, qPCR, gene synthesis, isothermal nucleic acid amplification technology (INAAT), microarray, hybridization, DNA sequencing, and next-generation sequencing (NGS).

“Academic research institutes are expected to dominate the market during the forecast period.”
Based on end user, the market is segmented into academic research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. The academic research institutes segment is expected to dominate the market during the forecast period. With the increasing funding pouring into institutes to conduct research, the demand for oligonucleotides is bound to increase. To meet this need, companies are launching products and entering into agreements with different research institutes to supply oligonucleotides for research purposes. For instance, in August 2015, Eurofins Genomics launched NGS tests for the identification of non-targeted microorganisms, including 16S Microbiome Profiling for academia and research.

“APAC to witness the highest growth during the forecast period.”

In 2017, North America is expected to account for the largest share of the market followed by Europe. However, Asia Pacific is expected to register the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligos, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 36%; Tier 2 – 46%; Tier 3 – 18%.
• By Designation: C-level- 26%; D-level- 45%; Others- 29%.
• By Region: North America-41%; Europe-31%; Asia Pacific-20%; Latin America- 5%, Middle East and Africa-3%

List of companies profiled in the report
• Agilent Technologies (US)
• ATDBio (UK)
• Bio-Synthesis (US)
• BioAutomation (US)
• LGC Biosearch Technologies (US)
• Eurofins Genomics (Germany)
• Eurogentec (Belgium)
• GeneDesign (Japan)
• GE Healthcare (US)
• GenScript (US)
• Integrated DNA Technologies (IDT) (US)
• Nitto Denko Avecia (US)
• Thermo Fisher Scientific (US)
• TriLink Biotechnologies (US)
• Sigma-Aldrich Corporation (Sigma-Aldrich) (US) (part of Merck KGAA (Germany)
Research Coverage:
The report provides an overview of the oligonucleotide synthesis market. It aims at estimating the market size and future growth potential of this market across different segments such as product, application, end user, and region. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall oligonucleotide synthesis market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies. The report also will also help stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 DEFINITION 22
1.3 MARKET SCOPE 23
1.3.1 MARKETS COVERED 23
1.3.2 YEARS CONSIDERED FOR THE STUDY 24
1.4 CURRENCY 24
1.5 LIMITATIONS 24
1.6 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
2.2 SECONDARY DATA 27
2.2.1 SECONDARY SOURCES 27
2.3 PRIMARY DATA 28
2.3.1 KEY DATA FROM PRIMARY SOURCES 28
2.3.2 KEY INDUSTRY INSIGHTS 29
2.4 MARKET SIZE ESTIMATION 30
2.4.1 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 30
2.4.2 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 31
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.6 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 39
4.1 ATTRACTIVE OPPORTUNITIES IN OLIGONUCLEOTIDE SYNTHESIS MARKET 39
4.2 OLIGONUCLEOTIDES SYNTHESIS MARKET, BY SYNTHESIZED OLIGONUCLEOTIDES PRODUCTS 40
4.3 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY SYNTHESIZED OLIGONUCLEOTIDES TYPE 40
4.4 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY RESEARCH APPLICATION AND COUNTRY 41
4.5 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY THERAPEUTIC APPLICATION 42
4.6 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER 43
4.7 GEOGRAPHIC SNAPSHOT: OLIGONUCLEOTIDE SYNTHESIS MARKET 44

5 MARKET OVERVIEW 45
5.1 INTRODUCTION 45
5.2 MARKET DRIVERS 46
5.2.1 INCREASING USE OF SYNTHESIZED OLIGONUCLEOTIDES IN MOLECULAR DIAGNOSTICS AND CLINICAL APPLICATIONS 46
5.2.2 INCREASING GOVERNMENT INVESTMENTS AND R&D EXPENDITURE IN PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 47
5.2.3 RISE IN VENTURE CAPITAL INVESTMENTS 48
5.3 MARKET RESTRAINTS 48
5.3.1 PRICE EROSION OF SYNTHESIZED OLIGONUCLEOTIDES 48
5.3.2 LACK OF A UNIFIED SET OF REGULATIONS FOR THERAPEUTIC OLIGONUCLEOTIDES 48
5.4 MARKET OPPORTUNITIES 49
5.4.1 EMERGING ASIAN MARKETS 49
5.5 MARKET CHALLENGES 50
5.5.1 LARGE-SCALE SYNTHESIS OF OLIGONUCLEOTIDES 50
5.5.2 DELIVERY OF OLIGONUCLEOTIDE DRUGS TO SPECIFIC TARGETS 50
5.6 INDUSTRY TRENDS 51
6 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT 52
6.1 INTRODUCTION 53
6.2 SYNTHESIZED OLIGONUCLEOTIDES 54
6.2.1 BY PRODUCT 57
6.2.1.1 Primers 57
6.2.1.2 Probes 60
6.2.1.3 Large-scale synthesis oligonucleotides 63
6.2.1.4 Intermediate-scale synthesis oligonucleotides 65
6.2.1.5 Linkers & Adaptors 68
6.2.2 BY TYPE 70
6.2.2.1 Custom oligonucleotides 71
6.2.2.2 Pre-designed oligonucleotides 74
6.3 REAGENTS 76
6.4 EQUIPMENT 79
7 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION 82
7.1 INTRODUCTION 83
7.2 RESEARCH 84
7.2.1 PCR 87
7.2.2 QPCR 89
7.2.3 SEQUENCING 91
7.2.4 GENE SYNTHESIS 93
7.2.5 OTHER RESEARCH APPLICATIONS 96
7.3 DIAGNOSTICS 98
7.4 THERAPEUTICS 101
7.4.1 RNAI 104
7.4.2 NUCLEIC ACID APTAMERS 107
7.4.3 DNA/ANTISENSE OLIGONUCLEOTIDES 109
7.4.4 IMMUNOTHERAPY APPLICATIONS 112
8 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER 115
8.1 INTRODUCTION 116
8.2 ACADEMIC RESEARCH INSTITUTES 117
8.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 120
8.4 DIAGNOSTIC LABORATORIES 123
8.5 OTHER END USERS 125
9 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION 128
9.1 INTRODUCTION 129
9.2 NORTH AMERICA 130
9.2.1 US 135
9.2.2 CANADA 139
9.3 EUROPE 143
9.3.1 GERMANY 149
9.3.2 FRANCE 153
9.3.3 UK 157
9.3.4 REST OF EUROPE (ROE) 161
9.4 ASIA PACIFIC (APAC) 166
9.4.1 CHINA 171
9.4.2 JAPAN 175
9.4.3 INDIA 179
9.4.4 REST OF ASIA PACIFIC (ROAPAC) 183
9.5 LATIN AMERICA 188
9.5.1 BRAZIL 193
9.5.2 MEXICO 194
9.5.3 REST OF LATIN AMERICA 196
9.6 MIDDLE EAST & AFRICA 198
10 COMPETITIVE LANDSCAPE 203
10.1 OVERVIEW 203
10.2 MARKET SHARE ANALYSIS 204
10.3 COMPETITIVE SCENARIO 207
10.3.1 PARTNERSHIPS, AGREEMENTS, CONTRACTS, AND COLLABORATIONS 207
10.3.2 PRODUCT LAUNCHES, UPGRADES, AND APPROVALS 207
10.3.3 EXPANSIONS 208
10.3.4 ACQUISITIONS 209
11 COMPANY PROFILES 210
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View)*
11.1 INTEGRATED DNA TECHNOLOGIES 210
11.2 MERCK KGAA 216
11.3 EUROFINS GENOMICS 222
11.4 THERMO FISHER SCIENTIFIC 226
11.5 BIOAUTOMATION 230
11.6 AGILENT TECHNOLOGIES 233
11.7 EUROGENTEC 241
11.8 GE HEALTHCARE 245
11.9 LGC BIOSEARCH TECHNOLOGIES 249
11.10 NITTO DENKO AVECIA 251
11.11 GENSCRIPT 254
11.12 GENEDESIGN (PART OF AJINOMOTO) 257
11.13 TRILINK BIOTECHNOLOGIES (PART OF MARAVAI LIFESCIENCES) 259
11.14 BIO-SYNTHESIS 261
11.15 ATDBIO 263
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, Mnm View might not be captured in case of unlisted companies.
12 APPENDIX 264
12.1 INSIGHTS FROM INDUSTRY EXPERTS 264
12.2 DISCUSSION GUIDE 265
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 268
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 270
12.5 AVAILABLE CUSTOMIZATIONS 270
12.6 RELATED REPORTS 271
12.7 AUTHOR DETAILS 272

LIST OF TABLESU

TABLE 1 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY REGION, 2015–2022 (USD MILLION) 55
TABLE 2 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 55
TABLE 3 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 4 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 56
TABLE 5 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT TYPE, 2015–2022 (USD MILLION) 57
TABLE 6 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS, BY REGION,
2015–2022 (USD MILLION) 58
TABLE 7 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS,
BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 8 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS, BY COUNTRY, 2015–2022 (USD MILLION) 59
TABLE 9 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRIMERS,
BY COUNTRY, 2015–2022 (USD MILLION) 60
TABLE 10 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES, BY REGION,
2015–2022 (USD MILLION) 61
TABLE 11 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES,
BY COUNTRY, 2015–2022 (USD MILLION) 61
TABLE 12 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES, BY COUNTRY, 2015–2022 (USD MILLION) 62
TABLE 13 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PROBES, BY COUNTRY, 2015–2022 (USD MILLION) 62
TABLE 14 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY REGION, 2015–2022 (USD MILLION) 63
TABLE 15 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 64
TABLE 16 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 64
TABLE 17 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LARGE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 65
TABLE 18 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY REGION, 2015–2022 (USD MILLION) 66
TABLE 19 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 66
TABLE 20 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 67
TABLE 21 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 67
TABLE 22 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS & ADAPTORS, BY REGION, 2015–2022 (USD MILLION) 68
TABLE 23 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS
& ADAPTORS, BY COUNTRY, 2015–2022 (USD MILLION) 68
TABLE 24 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS & ADAPTORS,
BY COUNTRY, 2015–2022 (USD MILLION) 69
TABLE 25 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR LINKERS & ADAPTORS, BY COUNTRY, 2015–2022 (USD MILLION) 69
TABLE 26 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 71
TABLE 27 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES,
BY REGION, 2015–2022 (USD MILLION) 72
TABLE 28 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 72
TABLE 29 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 73
TABLE 30 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR CUSTOM OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 73
TABLE 31 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY REGION, 2015–2022 (USD MILLION) 74
TABLE 32 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 75
TABLE 33 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 75
TABLE 34 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PRE-DESIGNED OLIGONUCLEOTIDES, BY COUNTRY, 2015–2022 (USD MILLION) 76
TABLE 35 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS, BY REGION,
2015–2022 (USD MILLION) 77
TABLE 36 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS,
BY COUNTRY, 2015–2022 (USD MILLION) 77
TABLE 37 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS, BY COUNTRY, 2015–2022 (USD MILLION) 78
TABLE 38 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR REAGENTS,
BY COUNTRY, 2015–2022 (USD MILLION) 78
TABLE 39 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT, BY REGION,
2015–2022 (USD MILLION) 79
TABLE 40 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT,
BY COUNTRY, 2015–2022 (USD MILLION) 80
TABLE 41 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT, BY COUNTRY, 2015–2022 (USD MILLION) 80
TABLE 42 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR EQUIPMENT,
BY COUNTRY, 2015–2022 (USD MILLION) 81
TABLE 43 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015-2022 (USD MILLION) 83
TABLE 44 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015-2022 (USD MILLION) 84
TABLE 45 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS,
BY REGION, 2015-2022 (USD MILLION) 85
TABLE 46 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 85
TABLE 47 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 86
TABLE 48 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 86
TABLE 49 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS, BY REGION, 2015-2022 ( USD MILLION) 87
TABLE 50 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 87
TABLE 51 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS,
BY COUNTRY, 2015-2022 (USD MILLION) 88
TABLE 52 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PCR APPLICATIONS,
BY COUNTRY, 2015-2022 (USD MILLION) 88
TABLE 53 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY REGION, 2015-2022 (USD MILLION) 89
TABLE 54 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 89
TABLE 55 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS,
BY COUNTRY, 2015-2022 (USD MILLION) 90
TABLE 56 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR QPCR APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 90
TABLE 57 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS,
BY REGION, 2015–2022(USD MILLION) 91
TABLE 58 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2015-2022 (USD MILLION) 92
TABLE 59 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 92
TABLE 60 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SEQUENCING APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 93
TABLE 61 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS,
BY REGION, 2015–2022 (USD MILLION) 94
TABLE 62 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 94
TABLE 63 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 95
TABLE 64 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR GENE SYNTHESIS APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 95
TABLE 65 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS,
BY REGION, 2015–2022 (USD MILLION) 96
TABLE 66 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 97
TABLE 67 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 97
TABLE 68 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER RESEARCH APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 98
TABLE 69 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2015–2022 (USD MILLION) 99
TABLE 70 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 99
TABLE 71 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 100
TABLE 72 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 100
TABLE 73 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 102
TABLE 74 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,
BY REGION, 2015–2022 (USD MILLION) 102
TABLE 75 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 103
TABLE 76 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 103
TABLE 77 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 104
TABLE 78 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 105
TABLE 79 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 106
TABLE 80 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS,
BY COUNTRY, 2015–2022 (USD MILLION) 106
TABLE 81 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RNAI APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 107
TABLE 82 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 108
TABLE 83 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 108
TABLE 84 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 109
TABLE 85 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR NUCLEIC ACID APTAMER APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 109
TABLE 86 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY REGION, 2015–2022 (USD MILLION) 110
TABLE 87 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 110
TABLE 88 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 111
TABLE 89 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DNA/ANTISENSE OLIGO APPLICATIONS, BY COUNTRY, 2015–2022 (USD MILLION) 111
TABLE 90 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS,
BY REGION, 2015–2022 (USD THOUSAND) 112
TABLE 91 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2014-2021 (USD THOUSAND) 113
TABLE 92 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2015–2022 (USD THOUSAND) 113
TABLE 93 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR IMMUNOTHERAPY APPLICATIONS, BY COUNTRY, 2015–2022 (USD THOUSAND) 114
TABLE 94 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,2015–2022 (USD MILLION) 117
TABLE 95 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2022 (USD MILLION) 118
TABLE 96 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION) 119
TABLE 97 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION) 119
TABLE 98 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2015–2022 (USD MILLION) 120
TABLE 99 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION) 121
TABLE 100 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION) 121
TABLE 101 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION) 122
TABLE 102 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL
AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015–2022 (USD MILLION) 122
TABLE 103 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2015–2022 (USD MILLION) 123
TABLE 104 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2015–2022 (USD MILLION) 124
TABLE 105 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2015–2022 (USD MILLION) 124
TABLE 106 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2015–2022 (USD MILLION) 125
TABLE 107 OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS, BY REGION, 2015–2022 (USD MILLION) 126
TABLE 108 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS, BY COUNTRY, 2015–2022 (USD MILLION) 126
TABLE 109 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS,
BY COUNTRY, 2015–2022 (USD MILLION) 127
TABLE 110 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR OTHER END USERS,
BY COUNTRY, 2015–2022 (USD MILLION) 127
TABLE 111 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY REGION, 2015–2022 (USD MILLION) 129
TABLE 112 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 131
TABLE 113 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 132
TABLE 114 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 132
TABLE 115 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 133
TABLE 116 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 133
TABLE 117 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 134
TABLE 118 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 134
TABLE 119 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 135
TABLE 120 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 136
TABLE 121 US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT 2015–2022 (USD MILLION) 136
TABLE 122 US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 137
TABLE 123 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 137
TABLE 124 US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 138
TABLE 125 US: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 138
TABLE 126 US: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 139
TABLE 127 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 140
TABLE 128 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 140
TABLE 129 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 140
TABLE 130 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 141
TABLE 131 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 142
TABLE 132 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 142
TABLE 133 CANADA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 143
TABLE 134 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 145
TABLE 135 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 145
TABLE 136 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 146
TABLE 137 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 146
TABLE 138 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 147
TABLE 139 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 147
TABLE 140 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 148
TABLE 141 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 148
TABLE 142 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 150
TABLE 143 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 150
TABLE 144 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 151
TABLE 145 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 151
TABLE 146 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 152
TABLE 147 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 152
TABLE 148 GERMANY: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 153
TABLE 149 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 154
TABLE 150 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 154
TABLE 151 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 155
TABLE 152 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 155
TABLE 153 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 156
TABLE 154 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 156
TABLE 155 FRANCE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 157
TABLE 156 UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 158
TABLE 157 UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 158
TABLE 158 UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 159
TABLE 159 UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 159
TABLE 160 UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 160
TABLE 161 UK: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 160
TABLE 162 UK: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 161
TABLE 163 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 162
TABLE 164 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 162
TABLE 165 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 163
TABLE 166 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 163
TABLE 167 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 164
TABLE 168 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 164
TABLE 169 ROE: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 165
TABLE 170 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY,
2015–2022 (USD MILLION) 167
TABLE 171 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 168
TABLE 172 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 168
TABLE 173 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE,2015–2022 (USD MILLION) 169
TABLE 174 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 169
TABLE 175 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 170
TABLE 176 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 170
TABLE 177 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 171
TABLE 178 CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 172
TABLE 179 CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 172
TABLE 180 CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE 2015–2022 (USD MILLION) 173
TABLE 181 CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 173
TABLE 182 CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 174
TABLE 183 CHINA: OLIGONUCLEOTIDE MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 174
TABLE 184 CHINA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 175
TABLE 185 JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 176
TABLE 186 JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 176
TABLE 187 JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 177
TABLE 188 JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 177
TABLE 189 JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 178
TABLE 190 JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 178
TABLE 191 JAPAN: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 179
TABLE 192 INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 180
TABLE 193 INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 180
TABLE 194 INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 181
TABLE 195 INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 181
TABLE 196 INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS,
BY TYPE, 2015–2022 (USD MILLION) 182
TABLE 197 INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 182
TABLE 198 INDIA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 183
TABLE 199 ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 184
TABLE 200 ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 184
TABLE 201 ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 185
TABLE 202 ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 185
TABLE 203 ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 186
TABLE 204 ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 186
TABLE 205 ROAPAC: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 187
TABLE 206 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY COUNTRY/REGION, 2015–2022 (USD MILLION) 189
TABLE 207 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 189
TABLE 208 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY PRODUCT, 2015–2022 (USD MILLION) 190
TABLE 209 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 190
TABLE 210 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 191
TABLE 211 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 191
TABLE 212 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 192
TABLE 213 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 192
TABLE 214 BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 193
TABLE 215 BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 193
TABLE 216 BRAZIL: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 194
TABLE 217 MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 195
TABLE 218 MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 195
TABLE 219 MEXICO: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 196
TABLE 220 ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT,
2015–2022 (USD MILLION) 196
TABLE 221 ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION,
2015–2022 (USD MILLION) 197
TABLE 222 ROLATAM: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER,
2015–2022 (USD MILLION) 197
TABLE 223 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY PRODUCT, 2015–2022 (USD MILLION) 199
TABLE 224 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS FOR SYNTHESIZED OLIGONUCLEOTIDES, BYPRODUCT, 2015–2022 (USD MILLION) 200
TABLE 225 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR SYNTHESIZED OLIGONUCLEOTIDES, BY TYPE, 2015–2022 (USD MILLION) 200
TABLE 226 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY APPLICATION, 2015–2022 (USD MILLION) 201
TABLE 227 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR RESEARCH APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 201
TABLE 228 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION) 202
TABLE 229 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2015–2022 (USD MILLION) 202
TABLE 230 EXCHANGE RATES (USED FOR THE CONVERSION OF EUR TO USD) 217


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 26
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 29
FIGURE 3 DATA TRIANGULATION METHODOLOGY 32
FIGURE 4 SYNTHESIZED OLIGONUCLEOTIDES SEGMENT TO DOMINATE THE GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET DURING THE FORECAST PERIOD 34
FIGURE 5 INTERMEDIATE-SCALE SYNTHESIS OLIGONUCLEOTIDES SEGMENT TO REGISTER THE HIGHEST GROWTH (2017–2022) 35
FIGURE 6 CUSTOM OLIGOS TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS MARKET 36
FIGURE 7 RESEARCH APPLICATIONS TO DOMINATE THE OLIGONUCLEOTIDE SYNTHESIS MARKET IN 2017 37
FIGURE 8 DIAGNOSTIC LABORATORIES END USER SEGMENT TO REGISTER THE HIGHEST CAGR (2017–2022) 37
FIGURE 9 NORTH AMERICA TO HOLD THE LARGEST SHARE IN 2017 AND ASIA PACIFIC
TO WITNESS THE HIGHEST GROWTH (2017–2022) 38
FIGURE 10 INCREASING RESEARCH ACTIVITIES AND GROWTH IN THE FIELDS OF MOLECULAR DIAGNOSTICS AND NGS ARE DRIVING MARKET GROWTH 39
FIGURE 11 PRIMERS TO FORM THE MAJOR CONTRIBUTING SEGMENT OF THE SYNTHESIZED OLIGONUCLEOTIDES MARKET (2017–2022) 40
FIGURE 12 CUSTOM OLIGOS TO DOMINATE THE SYNTHESIZED OLIGONUCLEOTIDES MARKET FROM 2017 TO 2022 40
FIGURE 13 PCR TO COMMAND THE LARGEST SHARE OF THE EUROPEAN RESEARCH APPLICATIONS MARKET IN 2017 41
FIGURE 14 RNAI SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 42
FIGURE 15 DIAGNOSTIC LABORATORIES TO WITNESS HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 43
FIGURE 16 CHINA TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 44
FIGURE 17 OLIGONUCLEOTIDE SYNTHESIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 45
FIGURE 18 OLIGONUCLEOTIDE SYNTHESIS MARKET: INDUSTRY TRENDS 51
FIGURE 19 SYNTHESIZED OLIGONUCLEOTIDES TO GROW AT THE HIGHEST CAGR DURING
THE FORECAST PERIOD 53
FIGURE 20 ASIA PACIFIC TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 54
FIGURE 21 CUSTOM OLIGONUCLEOTIDES TO COMMAND THE LARGEST SHARE OF SYNTHESIZED OLIGONUCLEOTIDES MARKET IN 2016 70
FIGURE 22 DIAGNOSTIC APPLICATIONS SEGMENT OFFERS LUCRATIVE GROWTH OPPORTUNITIES DURING THE FORECAST PERIOD 83
FIGURE 23 OLIGONUCLEOTIDE SYNTHESIS MARKET, BY END USER, 2017 VS. 2022 116
FIGURE 24 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN THE OLIGONUCLEOTIDE SYNTHESIS MARKET FOR ACADEMIC RESEARCH INSTITUTES 118
FIGURE 25 NORTH AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 130
FIGURE 26 EUROPE: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 144
FIGURE 27 ASIA PACIFIC: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 166
FIGURE 28 LATIN AMERICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 188
FIGURE 29 MIDDLE EAST & AFRICA: OLIGONUCLEOTIDE SYNTHESIS MARKET SNAPSHOT 198
FIGURE 30 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2014 AND 2017 203
FIGURE 31 MARKET EVOLUTION FRAMEWORK 204
FIGURE 32 GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016 205
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT 216
FIGURE 34 EUROFINS SCIENTIFIC GROUP: COMPANY SNAPSHOT 222
FIGURE 35 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 226
FIGURE 36 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT 233
FIGURE 37 KANEKA: COMPANY SNAPSHOT 241
FIGURE 38 GENERAL ELECTRIC COMPANY (GE): COMPANY SNAPSHOT 245
FIGURE 39 NITTO DENKO GROUP: COMPANY SNAPSHOT 251
FIGURE 40 GENSCRIPT: COMPANY SNAPSHOT 254


★調査レポート[オリゴヌクレオチド合成の世界市場予測(~2022年):商品別(プライマー、プローブ、リンカー、アダプター、カスタムオリゴ、試薬、機器)、用途別(PPCR、DNA、RNAi、研究、治療)、エンドユーザー別(学術研究機関、医薬品、バイオテクノロジー)] ( Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022 / MAM-BT-2680) 販売に関する免責事項
[オリゴヌクレオチド合成の世界市場予測(~2022年):商品別(プライマー、プローブ、リンカー、アダプター、カスタムオリゴ、試薬、機器)、用途別(PPCR、DNA、RNAi、研究、治療)、エンドユーザー別(学術研究機関、医薬品、バイオテクノロジー)] ( Oligonucleotide Synthesis Market by Product (Primer, Probe, Linker, Adaptor, Custom, Reagent, Equipment), Application (PCR, DNA, RNAi, Research, Therapeutic), End User (Academic, Pharmaceutical, Biotechnology) - Global Forecast to 2022 / MAM-BT-2680) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆